ce policies, anytime from anywhere using the Internet. MMR's principal product, the MyMedicalRecords PHR service, accessed through
www.mymedicalrecords.com, is built on proprietary patent-pending technology that enables users to transmit documents, images and voicemail messages in and out of the MyMedicalRecords PHR system using a variety of methods, including fax, phone, and file upload without relying on any specific electronic medical record platform to populate a user's account. Users and medical providers can fax paper records (such as laboratory tests, radiology reports and physician's notes), or scanned images can be uploaded, into a secured personal account, which the user can access and organize as necessary, including filing particularly sensitive documents in virtual lockboxes protected by secondary passwords, and designating certain records as accessible to medical personnel and first responders by way of a separate Emergency Login. MMR also offers its MyEsafeDepositBox service, available at
www.myesafedepositbox.com, which is designed to provide secure online storage for vital financial, legal and insurance documents in addition to medical records using the same patent-pending technologies that drive the MyMedicalRecords PHR service. In its final stages of development, MMR's MyMedicalRecords Pro service is designed to give physician's offices a cost-effective solution to the expensive and time-consuming problem of digitizing paper-based medical records. MMR clients include AFL-CIO, Alexian Brothers Hospital Network, Coverdell, MedicAlert, Midwest Research Institute, Qvisory, XN Financial and others. MMR is also one of the integrated service providers that launched on Google Health. Additional information regarding MMR's business and its products, including trial accounts, is available at
'/>"/>SOURCE MMR Information Systems, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
Researchers measure carbon nanotube interaction2.
Positive Outcome of Drug-Drug Interaction Trial With Intravenous Iclaprim3.
Scientists discover new method of observing interactions in nanoscale systems4.
Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research5.
Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice6.
Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials7.
Novel Approach to Treat Alzheimers and Other Diseases Offered by Targeting Cell Membrane RAFTS8.
CNS Response Announces Fiscal Third Quarter 2007 Results9.
Response Genetics Reports Second Quarter 2007 Financial Results10.
Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination11.
Response Genetics Announces Presentations/Webcasts at Upcoming Investor Conferences